Keith Devas
Stock Analyst at Jefferies
(0.54)
# 4,047
Out of 4,457 analysts
27
Total ratings
21.4%
Success rate
-11.7%
Average return
Main Sectors:
Stocks Rated by Keith Devas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Reiterated: Buy | $785 → $792 | $535.93 | +47.78% | 4 | May 6, 2026 | |
| PBH Prestige Consumer Healthcare | Maintained: Hold | $71 → $66 | $48.03 | +37.41% | 4 | Jan 30, 2026 | |
| KVUE Kenvue | Downgraded: Hold | $23 → $18 | $19.07 | -5.61% | 15 | Jan 30, 2026 | |
| PRGO Perrigo Company | Maintained: Hold | $27 → $23 | $10.05 | +128.86% | 4 | Oct 27, 2025 |
IDEXX Laboratories
May 6, 2026
Reiterated: Buy
Price Target: $785 → $792
Current: $535.93
Upside: +47.78%
Prestige Consumer Healthcare
Jan 30, 2026
Maintained: Hold
Price Target: $71 → $66
Current: $48.03
Upside: +37.41%
Kenvue
Jan 30, 2026
Downgraded: Hold
Price Target: $23 → $18
Current: $19.07
Upside: -5.61%
Perrigo Company
Oct 27, 2025
Maintained: Hold
Price Target: $27 → $23
Current: $10.05
Upside: +128.86%